ReNeuron Group PLC (FRA:RQE1)
€ 0.034 0 (0%) Market Cap: 2.28 Mil Enterprise Value: -3.31 Mil PE Ratio: 0 PB Ratio: 0.80 GF Score: 0/100

Half Year 2021 ReNeuron Group PLC Earnings Call Transcript

Jan 06, 2021 / 10:00AM GMT
Release Date Price: €1.03
Olav Hellebo
ReNeuron Group plc - CEO & Director

Good morning, everyone, and a very happy new year to everyone. Thanks for attending this analyst meeting. I'm Olav Hellebo, CEO; and as mentioned, Michael Hunt, our Chief Financial Officer, is on the call as well.

Before we begin the presentation, just want to make sure everyone either has today's slides in front of them or know how to get them. A copy has been e-mailed to you. If you haven't received it, then you can go to the Investors section of our website and pick them down there. So let's, with that, jump into the presentation that I hope you're looking at. Page 2 has the disclaimer. So I'll leave that for your perusal.

On Page 3, we can go to the Board members and some selected members of the management team. What I wanted to focus on, on that page actually is the worldwide experts in cell and gene therapy for ophthalmology that we're working with. We have the best of the best when it comes to getting advice in our program here. Dr. Jason Comander is at Mass Eye and Ear, which is part of Harvard. And he has treated -- he is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot